Remove DNA Remove Doctors Remove Presentation
article thumbnail

Injectable agents could improve liquid biopsy for cancer detection and monitoring

Broad Institute

McAlpine January 18, 2024 Credit: Susanna Hamilton, Broad Communications One of the new "priming agents" works by preventing immune cells from engulfing tumor DNA circulating in the bloodstream. Liquid biopsies promise to transform how cancers are diagnosed, monitored, and treated by detecting DNA that tumors shed into the blood.

DNA 133
article thumbnail

Largest-ever genetic study of epilepsy finds possible therapeutic targets

Broad Institute

In the future, the results could also help doctors tailor treatments to a patient’s genome. Since URVs are so rare, and because the scientists wanted to understand many different types of epilepsy, the researchers analyzed DNA from people across the world with a range of different genetic ancestries to find meaningful signals.

DNA 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Women in Stem with Dr Emily Leproust

Drug Target Review

After some time in that role and launching several products, I received a call from Bill Banyai and Bill Peck, or ‘The Bills’ as we call them, who were building a company around technology that creates DNA by ‘writing’ it on a silicon chip. I originally wanted to be a doctor but that’s a second-tier track in France.

DNA 116
article thumbnail

Roche to present data from industry leading portfolio at ESMO.

The Pharma Data

First data to be presented from the phase II coopERA Breast Cancer study evaluating neoadjuvant giredestrant treatment for oestrogen receptor (ER)-positive, HER2-negative breast cancer. In CUP, doctors cannot identify the location of the original (primary) tumour and can only find metastases. Breast Cancer Highlights.

article thumbnail

FDA Returns Disappointing News for ALS Stem Cell Therapy

PLOS: DNA Science

Last week DNA Science covered a setback in a clinical trial of a gene therapy for Duchenne muscular dystrophy (DMD). It aims to correct the faulty instructions at the DNA level, straightforward, at least conceptually, because mutations are deletions, of part or all of the gene. That’s not the case for ALS.

Therapies 105
article thumbnail

Overcoming operational challenges in CGT manufacturing with AI

Drug Target Review

At the recent ISCT 2024 – Signature Series, researchers from Charles River Laboratories presented a study 1 to predict the optimal cell culture parameters using a ML model. He holds a doctorate and conducted post-doctoral studies at Thomas Jefferson University, School of Medicine.

article thumbnail

The Love Songs of W. E. B. Du Bois Celebrates Afro-Indigenous History with Genealogy – No DNA Needed

PLOS: DNA Science

Du Bois , the first novel by award-winning poet Honoree Fanonne Jeffers, traces an American Black family back eight generations, through the eyes of Ailey Pearl Garfield, who untangles her own origins while doing research for a doctorate in American history. So his memories connect past to present, fleshing out the archival documents.

DNA 89